Glenmede Trust’s Twist Bioscience TWST Stock Holding History

Glenmede Trust’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-654	Closed	-$49K	–	2198
2020 Q3	$49K	Buy	+654	New	+$40.7K	﹤0.01%	1338

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Glenmede Trust's TWST Position: Q4 2020 in Review

Glenmede Trust sold out of Twist Bioscience (TWST) in Q4 2020, closing a stake of 654 shares — an estimated $49K sold.

Glenmede Trust first reported a position in TWST in Q3 2020 and held it in 1 quarter. The position peaked at $49K in Q3 2020. 222 funds tracked by Wall St. Rank hold TWST as of Q4 2020.

Glenmede Trust reported no remaining Twist Bioscience position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 654 Twist Bioscience shares in Q4 2020, an estimated $49K.
Glenmede Trust first reported a position in Twist Bioscience in Q3 2020 and held it in 1 quarter.
Glenmede Trust's Twist Bioscience position peaked at $49K in Q3 2020.
222 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.